Literature DB >> 15903153

Asymmetry in auditory and spatial attention span in normal elderly genetically at risk for Alzheimer's disease.

Mark W Jacobson1, Dean C Delis, Mark W Bondi, David P Salmon.   

Abstract

Some studies of elderly individuals with the ApoE-e4 genotype noted subtle deficits on tests of attention such as the WAIS-R Digit Span subtest, but these findings have not been consistently reported. One possible explanation for the inconsistent results could be the presence of subgroups of e4+ individuals with asymmetric cognitive profiles (i.e., significant discrepancies between verbal and visuospatial skills). Comparing genotype groups with individual, modality-specific tests might obscure subtle differences between verbal and visuospatial attention in these asymmetric subgroups. In this study, we administered the WAIS-R Digit Span and WMS-R Visual Memory Span subtests to 21 nondemented elderly e4+ individuals and 21 elderly e4- individuals matched on age, education, and overall cognitive ability. We hypothesized that a) the e4+ group would show a higher incidence of asymmetric cognitive profiles when comparing Digit Span/Visual Memory Span performance relative to the e4- group; and (b) an analysis of individual test performance would fail to reveal differences between the two subject groups. Although the groups' performances were comparable on the individual attention span tests, the e4+ group showed a significantly larger discrepancy between digit span and spatial span scores compared to the e4- group. These findings suggest that contrast measures of modality-specific attentional skills may be more sensitive to subtle group differences in at-risk groups, even when the groups do not differ on individual comparisons of standardized test means. The increased discrepancy between verbal and visuospatial attention may reflect the presence of "subgroups" within the ApoE-e4 group that are qualitatively similar to asymmetric subgroups commonly associated with the earliest stages of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15903153      PMCID: PMC3080769          DOI: 10.1080/13803390490515441

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  57 in total

1.  Phonological loop and central executive functioning in Alzheimer's disease.

Authors:  F Collette; M Van der Linden; S Bechet; E Salmon
Journal:  Neuropsychologia       Date:  1999-07       Impact factor: 3.139

2.  Neuropsychological asymmetry in Alzheimer's disease: verbal versus visuoconstructional deficits across stages of dementia.

Authors:  D Strite; P J Massman; N Cooke; R S Doody
Journal:  J Int Neuropsychol Soc       Date:  1997-09       Impact factor: 2.892

3.  Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women.

Authors:  K Yaffe; J Cauley; L Sands; W Browner
Journal:  Arch Neurol       Date:  1997-09

4.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

5.  Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.

Authors:  G E Smith; D L Bohac; S C Waring; E Kokmen; E G Tangalos; R J Ivnik; R C Petersen
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

6.  Functional anatomy of verbal and visuospatial span tasks in Alzheimer's disease.

Authors:  F Collette; E Salmon; M Van der Linden; C Degueldre; G Franck
Journal:  Hum Brain Mapp       Date:  1997       Impact factor: 5.038

7.  Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.

Authors:  R J Caselli; N R Graff-Radford; E M Reiman; A Weaver; D Osborne; J Lucas; A Uecker; S N Thibodeau
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

8.  The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment.

Authors:  R J Perry; P Watson; J R Hodges
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

9.  California Verbal Learning Test: normative data for the elderly.

Authors:  A M Paolo; A I Troster; J J Ryan
Journal:  J Clin Exp Neuropsychol       Date:  1997-04       Impact factor: 2.475

10.  Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study.

Authors:  C Geroldi; M P Laakso; C DeCarli; A Beltramello; A Bianchetti; H Soininen; M Trabucchi; G B Frisoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

View more
  12 in total

Review 1.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

Review 2.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

3.  Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness.

Authors:  Yu-Ling Chang; Mark W Jacobson; Christine Fennema-Notestine; Donald J Hagler; Robin G Jennings; Anders M Dale; Linda K McEvoy
Journal:  Cereb Cortex       Date:  2009-09-23       Impact factor: 5.357

4.  Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Authors:  Amy L Bauernfeind; Mary S Dietrich; Jennifer U Blackford; Evonne J Charboneau; James G Lillevig; Christopher J Cannistraci; Neil D Woodward; Aize Cao; Tristan Watkins; Christina R Di Iorio; Carissa Cascio; Ronald M Salomon; Ronald L Cowan
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

Review 5.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

Review 6.  Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD.

Authors:  Mark W Jacobson; Linda K McEvoy; Anders Dale; Christine Fennema-Notestine
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

7.  The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Authors:  Mark W Jacobson; Dean C Delis; Guerry M Peavy; Spencer R Wetter; Erin D Bigler; Tracy J Abildskov; Mark W Bondi; David P Salmon
Journal:  Neurocase       Date:  2009-04-21       Impact factor: 0.881

8.  Apolipoprotein E genotype and memory in the sixth decade of life.

Authors:  M R Schultz; M J Lyons; C E Franz; M D Grant; C Boake; K C Jacobson; H Xian; G D Schellenberg; S A Eisen; W S Kremen
Journal:  Neurology       Date:  2008-01-30       Impact factor: 9.910

9.  Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study.

Authors:  Eric M Fine; Dean C Delis; Spencer R Wetter; Mark W Jacobson; Amy J Jak; Carrie R McDonald; Jodessa C Braga; Leon J Thal; David P Salmon; Mark W Bondi
Journal:  Am J Geriatr Psychiatry       Date:  2008-05       Impact factor: 4.105

10.  Linear and nonlinear relationships between cognitive subdomains of ability discrepancy and Alzheimer's disease biomarkers.

Authors:  Ian M McDonough; Taylor E Popp
Journal:  Neuropsychology       Date:  2019-12-02       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.